跳至主要内容
临床试验/NCT06133647
NCT06133647招募中不适用

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

Methodist Health System1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2023年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
8
试验地点
1
主要终点
Determine the complications of Treatment in patients with MBC and FBC

研究概览

简要总结

To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).

详细描述

Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast

排除标准

  • 18 years of age
  • Prisoners
  • Pregnant or breastfeeding

结局指标

主要结局

Determine the complications of Treatment in patients with MBC and FBC

时间窗: 13 years

Determine the complications of Treatment in patients with MBC and FBC

Diagnosis Rates of patients with MBC and FBC

时间窗: 13 years

complications of treatment

Recurrence rates of Patients with MBC and FBC

时间窗: 13 years

Recurrence rates of Patients with MBC and FBC

Duration of remission in Patients with MBC and FBC

时间窗: 13 years

Duration of remission in Patients with MBC and FBC

The Overall Survival of patients with MBC and FBC after receiving treatment

时间窗: 13 years

The Overall Survival of patients with MBC and FBC after receiving treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验